Plant-derived anticancer agents: a promising treatment for bone metastasis

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Bone metastasis is a frequent, incurable complication of advanced cancer.
• Current therapies offer limited efficacy, delaying but not curing the disease, and can cause side effects.
• There is a critical need for novel, effective, and safer therapeutic strategies for bone metastases.

Purpose of the Study:

• To review and highlight promising plant-derived compounds for the treatment of bone metastasis.
• To underscore the potential of natural products in oncology, specifically for bone metastases.
• To identify compounds with the potential for clinical translation in managing bone metastatic disease.

Main Methods:

• Review of preclinical (in vitro and in vivo) studies on plant-derived compounds.
• Analysis of existing literature on natural products in cancer therapy.
• Focus on compounds evaluated for their efficacy against bone metastasis.

Main Results:

• Plant-derived compounds have demonstrated significant potential in preclinical studies for various cancers, including bone metastasis.
• A small but growing number of natural compounds have shown specific activity against bone metastases.
• Many plant species remain unexplored for their bioactive compounds with anticancer properties.

Conclusions:

• Plant-derived compounds represent a promising avenue for developing new therapies for bone metastasis.
• Targeting specific signaling pathways with natural agents may offer a strategy for effective and safer treatment.
• Further investigation and clinical evaluation of these compounds are warranted to combat bone metastatic disease.